LDX lumos diagnostics holdings limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

  1. 3,244 Posts.
    lightbulb Created with Sketch. 313
    So, in the past the CEO said he was going to put FebriDx aside and focus on the services business to generate revenue. However, here we are again with another FDA application for FebriDx.

    This should see the share price plummet once more during 2023. Oh, and again, no real update on what's happening with ViraDx. It was supposed to be in the US market months ago. Another false promise by Lumos Diagnostics. Are we surprised? No.

    It looks like there will be no news until early 2024. See you then.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.1¢
Change
0.008(11.0%)
Mkt cap ! $60.63M
Open High Low Value Volume
7.4¢ 8.5¢ 7.2¢ $2.126M 26.50M

Buyers (Bids)

No. Vol. Price($)
2 402988 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 18948 1
View Market Depth
Last trade - 16.10pm 01/08/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.